Resumen
La enfermedad coronaria es la principal causa de muerte a nivel mundial. Se han descrito factores de riesgo clásicos para desarrollarla, como la hipertensión y la diabetes mellitus; sin embargo, otras entidades como la esclerosis múltiple (EM) pueden aumentar el riesgo de cardiopatía isquémica en muchos pacientes, con una incidencia 24% mayor que en las personas sin EM, la cual puede ser debida a disfunción del sistema nervioso autónomo o a efectos adversos de medicamentos utilizados en esta patología. Describimos un caso de infarto agudo de miocardio en un paciente con EM y revisamos la asociación de estas dos enfermedades.
Citas
SPODICK DH. Differential characteristics of the electrocardiogram in early repolarization and acute pericarditis. N Engl J Med. 1976;295(10):523.
GINZTON LE, LAKS MM. The differential diagnosis of acute pericarditis from the normal variant: new electrocardiographic criteria. Circulation 1982;65(5):1004.
MARINELLA M. Electrocardiographic manifestations and differential diagnosis of acute pericarditis. Am Fam Physician 1998;57(4):699-704.
KOHSAKA S, MENON V, LOWE A, LANGE M, DZAVICK V, ET AL. Systemic Inflammatory Response Syndrome After Acute Myocardial Infarction Complicated by Cardiogenic Shock. Arch Intern Med. 2005;165:1643-50.
HAENSCH C, JORG J. Autonomic dysfunction in multiple sclerosis. J Neuro. 2006;253(Suppl 1):13-9.
WORLD HEALTH ORGANIZATION. Atlas Multiple Sclerosis Resources in the World, 2008. [Internet]. Disponible en http://www.who.int/mental_health/neurology/Atlas_MS_WEB.pdf.
TONCEV G, MILICIC B, TONCEV S, SAMARDZIC G. Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction. Eur J Neurol. 2002;9:221-6.
RENTZOS M, NIKOLAOU C, ANAGNOSTOULI M, ROMBOS A, TSAKANIKAS K, ET AL. Serum uric acid and multiple sclerosis. Clin Neurol Neurosurg. 2006;108:527-31.
FANG J, ALDERMAN MH. Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000;283:2404-10.
KIM SY, GUEVARA JP, KIM KM, CHOI HK, HEITJAN DF, ALBERT DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res. 2010;62:170-80.
KATRITSIS DG, ZOGRAFOS T, KOROVESIS S, ET AL. Antiendothelial cell antibodies in patients with coronary artery ectasia. Coron Artery Dis. 2010;21(6):352-6.
SUMMARIA F, MUSTILLI M, LANZILLO C, ROMAGNOLI E. Diffuse Coronary Ectasia Complicated by Myocardial Infarction in a Patient with Multiple Sclerosis-Transradial Dethrombosis and One-year Coronary Computed Tomography Angiography Follow-Up. Am Heart Hosp J. 2011;9(1):48-51.
ADAMEC I, HABEK M. Autonomic dysfunction in multiple sclerosis. Clin Neurol Neurosurg. 2013;1155:573-8.
SOROS P, HACHINSKI V. Cardiovascular and neurological causes of sudden death after ischaemic stroke. Lancet Neurol. 2012;11(2):179-88.
RAZAZIAN N, HEDAYATI N, MORADIAN N, BOSTANI A, AFSHARI D, ASGARI N. P Wave Duration and Dispersion ad QT Interval in Multiple Sclerosis. Mult Scler Relat Disord. 2014;3(5):662-5.
ALLEN N, LICHTMAN J, COHEN H, FANG J, BRASS LM, ET AL. Vascular disease among hospitalized Multiple Sclerosis Patients. Neuroepidemiology 2008;30:234-8.
CHRISTIANSEN C, CHRISTIANSEN S, FARKAS D, MIRET M. Risk of cardiovascular disease in patients with multiple sclerosis: a population-based cohort study. Neuroepidemiology 2010;35:267-74.
MARRIE R, YU B, LEUNG S, ELLIOT L, CAETANO P, WARREN S, WOLFSON C. Prevalence and Incidence of Ischemic Heart Disease in Multiple Sclerosis: A Population-Based Validation Study. Mult Scler Relat Disord. 2013;2:355-61.
SONNENBLICK M, ROSIN A. Cardiotoxicity of interferon. A review of 44 cases. Chest. 1991;99:557-61.
TERAGAWA H, HONDO T, AMANO H, HINO F, OHBAYASHI M. Adverse effects of interferon of the cardiovascular system in patients with chronic hepatitis C. Jpn Heart J. 1996;37:905-15.
KARLOV VA, MARAKOV VA, SABINA EV, SELEZNE AN, SAVIN AA. Role of disorders of the hemostatic system in the pathogenesis of multiple sclerosis and ways of correcting them. Zh Nevropatol Psikhiatr Im S S Korsakova 1985;85(2):198-206.
VANDENBERGHE N, DEBOUVERIA M, ANXIONNAT R, CLAVELOU P, BOULY S, ET AL. Cerebral venous thrombosis in four patients with multiple sclerosis. Eur J Neurol. 2003;10:63-6.
OCAK G, VOSSEN CY, VERDUIJIN M, DEKKER FW, ROSENDAAL FR, ET AL. Risk of venous thrombosis in patients with major illnesses: results from the MEGA study. J Thromb Haemost. 2013;11:116-23.
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.